Pharmacodynamic Dose-Response of S-Tenatoprazole-Na (STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2008
At a glance
- Drugs Esomeprazole; Tenatoprazole
- Indications Gastrointestinal disorders
- Focus Pharmacodynamics
- 21 Mar 2008 The expected completion date for this trial is now 1 Nov 2006, as reported by clinicaltrials.gov.
- 19 May 2007 Status change
- 19 May 2007 Results have been published.